Frank Mottola

Insider Reports History

Entity
Individual
Location
9715 Key West Avenue, Rockville, MD
Signature
/s/ Timothy C. Dec, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Frank Mottola:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUPERNUS PHARMACEUTICALS, INC. SVP, Quality, GMP, Ops, IT Common Stock 7.78K $217K $27.94 Feb 28, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Quality, GMP, Ops, IT Restricted Stock Unit 5.63K $163K $29.06 Feb 23, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Quality, GMP, Ops, IT Performance Share Unit 0 $0 $27.94 Feb 28, 2024 Direct
SUPERNUS PHARMACEUTICALS, INC. SVP, Quality, GMP, Ops, IT Employee Stock Option (Right to Buy) 25K Feb 22, 2024 Direct

Insider Reports Filed by Frank Mottola

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 28, 2024 3 -$12.9K 4 Feb 29, 2024 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2024 3 -$27.2K 4 Feb 27, 2024 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2024 6 -$9.36K 4 Feb 26, 2024 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Nov 14, 2023 3 -$12.7K 4 Nov 16, 2023 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Mar 14, 2023 1 -$172K 4 Mar 16, 2023 Sr VP, Quality, GMP Oper. & IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 23, 2023 2 $0 4 Feb 27, 2023 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2023 3 -$11.1K 4/A Apr 12, 2023 Sr VP, Quality, GMP Oper. & IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 16, 2023 3 -$29.2K 4 Feb 21, 2023 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Jan 12, 2023 1 $0 4 Jan 17, 2023 SVP, Quality, GMP, Ops, IT
SUPN SUPERNUS PHARMACEUTICALS, INC. Feb 22, 2022 2 $0 4/A Feb 25, 2022 SVP, Quality, GMP, Ops, IT